Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Tue, 03.02.2026
Eleving Group S.A.
Eleving Group invites investors, analysts, media representatives, and other stakeholders to the earnings call with the Management Board on 10 February 2026 at 15:00 CET, following the publication of its unaudited 12M 2025 results on 9 February 2026.
CEO Modestas Sudnius and CFO Maris Kreics will present the group’s financial performance and key hig [ … ]
Tue, 03.02.2026
Nordex SE
Hamburg, 3 February 2026. The Nordex Group has received a new order from the Swedish renewable energy company OX2 for the supply and installation of wind turbines for the Fageråsen Wind Farm in Sweden. The order comprises 27 Nordex N163/6.X turbines, which will be installed on 119-meter tubular steel towers, representing a total installed capacity [ … ]
Tue, 03.02.2026
Steyr Motors AG
Steyr Motors with double-digit growth in 2025 and strong outlook for 2026
Revenue and adjusted EBIT in line with the revised 2025 forecast
Revenue growth driven by both Civil and Defense segments
Significant sales potential unlocked
Outlook 2026: Strong revenue increase expected with rising EBIT margin
Steyr, Austria, 3 February 2026 – Steyr Mo [ … ]
Tue, 03.02.2026
Siltronic AG
Press release
Siltronic AG
Einsteinstraße 172
81677 Munichwww.siltronic.com
Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions
- Preliminary sales at EUR 1,347 million, declined by 4.7 percent year over year (Guidance 2025: mid single‑digit percent range below previous year)
- Prelim [ … ]
Tue, 03.02.2026
Newron Pharmaceuticals S.p.A.
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
Publication presents clinical findings highlighting evenamide’s glutamatergic modulation as a therapeutic strategy for patients with inadequate response or treatment-resistant schizophrenia (TRS)
By targeting the hippocamp [ … ]
Tue, 03.02.2026
AT&S Austria Technologie & Systemtechnik AG
AT&S records positive net profit again in the third quarter
Revenue increases to € 1.3 billion in the first three quarters of 2025/26, up 10% on 2024/25
EBITDA of € 297 million corresponds to a margin of 22.6%
Plants in Kulim and Leoben are developing as planned and contribute to revenue as expected
Exchange rate developments influe [ … ]
Tue, 03.02.2026
HUAWEI
SHENZHEN, China, Feb. 3, 2026 /PRNewswire/ -- On January 5, 2026, Huawei announced a revolutionary partnership as the official technology collaborator for the dsm-firmenich Running Team, home to marathon icon Eliud Kipchoge. The collaboration aims to promote running culture worldwide and inspire more people to embrace the sport. The cross-industry [ … ]
Mon, 02.02.2026
MediaLinks TV LLC
WASHINGTON, Feb. 2, 2026 /PRNewswire/ -- CGTN America & CCTV UN releases "Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy."
As the Year of the Horse approaches and the Spring Festival draws near, China Media Group presents "Prelude to the Spring Festival Gala - The World Watches the CMG [ … ]
Mon, 02.02.2026
Virtual Science AI Ltd
LONDON, Feb. 2, 2026 /PRNewswire/ -- Virtual Science AI announces the launch of Medical Congress AI, a conversational AI solution that captures and analyses insights from medical congress conversations – an industry first. Medical Congress AI has successfully been deployed at major congress events by top life sciences companies to positive feedback [ … ]
Mon, 02.02.2026
Joh. Berenberg, Gossler & Co. KG
NOT FOR DISTRIBUTION OR PUBLICATION IN THE UNITED STATES, CANADA, AUSTRALIA, OR JAPAN.Notification of the exercise of the Greenshoe-Option and Stabilization Measures in accordance with Art. 5 (4)(b), (5) and (6) of Reg. (EU) No 596/2014 ('MAR') of 16 April 2014 and in accordance with Art. 8 (f) and Art. 6 (3) of the Com. Delegated Reg. (EU) 2016/10 [ … ]
